Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible newly diagnosed multiple myeloma.

Jonathan Zung; Chief Development Officer; Curis Inc. Presentation. Operator. Good morning and welcome to Curis' fourth quarter 2024 business update call. (Operator I ...

Q4 2024 Earnings Call Transcript March 31, 2025 Operator: Good morning, and welcome to Curis’s Fourth Quarter 2024 Business ...

Your gut bacteria influence more than digestion. Discover how they affect cravings, immunity, mental health, and weight ...

A team-by-team look at what to expect from the Skyland Conference and area Union County Conference softball squads in 2025 ...

Claims related to these individual benefits, approved by the Food and Drug Administration (FDA), are included on the product label and in public ... indirect benefits can add substantially to ...

The preseason Courier News Top 10 softball rankings in the Skyland Conference and western Union County headed into the 2025 campaign ...

The year 2024 saw the first sales of their agent Rytelo in the space of lower risk myelodysplastic syndromes (MDS), and their work is continuing to extend the drug's reach into other labels.

Custom AI Companion add-on will allow organizations to customize ... AI Companion will be able to automatically label the columns so users can quickly see highlights and automate information ...

K9 Advantix II replaces Frontline Plus, our former top pick ... The product is extremely toxic to cats, as noted on the product label and insert. It's recommended to keep cats away from treated ...

VOLODYMYR Zelensky has visited drone-flying troops on Ukraine's frontline near a city that Russia ... planned for the armed forces, expected to add up to hundreds of billions of euros in the ...